Stock GLUE MONTE ROSA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Monte Rosa Therapeutics, Inc.

Equities

GLUE

US61225M1027

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-06-26 EDT 		5-day change 1st Jan Change
3.69 USD -2.64% Intraday chart for Monte Rosa Therapeutics, Inc. +3.65% -34.69%
06-14 Monte Rosa Therapeutics, Inc. Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis CI
05-30 Monte Rosa Therapeutics Names Three Insiders to Leadership Team MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Monte Rosa Therapeutics Names Three Insiders to Leadership Team
MT
Monte Rosa Therapeutics, Inc. Announces Executive Promotions
CI
Monte Rosa Therapeutics, Inc. Announces Departure of Owen Wallace as Chief Scientific Officer and Transition to Member of its Scientific Advisory Board
CI
Monte Rosa Therapeutics, Inc. Appoints Anthony M. Manning to the Board of Directors
CI
Monte Rosa Therapeutics Appoints Dr. Jan Skvarka to Board of Directors
CI
Monte Rosa Therapeutics Promotes Jullian Jones to Chief Business Officer
MT
Monte Rosa Therapeutics, Inc. Appoints Jullian G. Jones as Chief Business Officer
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. GLUE Stock
  4. News Monte Rosa Therapeutics, Inc.
  5. Insiders